Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer
about
Genetics and genomics of radiotherapy toxicity: towards predictionBig Data Analytics for Prostate RadiotherapyExploiting biological and physical determinants of radiotherapy toxicity to individualize treatmentTreatment of Radiation InjuryPharmacogenetics of follicle-stimulating hormone actionPharmacogenetics of erectile dysfunction: navigating into uncharted watersGenome-wide association study identifies eight new risk loci for polycystic ovary syndromePilot genome-wide association search identifies potential loci for risk of erectile dysfunction in type 1 diabetes using the DCCT/EDIC study cohort.Data-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers Era.Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.Association of XRCC1 and XRCC3 gene haplotypes with the development of radiation-induced fibrosis in patients with nasopharyngeal carcinomaGenetic predictors of cervical dysplasia in African American HIV-infected women: ACTG DACS 268.Genome-wide association analysis of radiation resistance in Drosophila melanogaster.A replicated association between polymorphisms near TNFα and risk for adverse reactions to radiotherapyIndividual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity.The current progress and future prospects of personalized radiogenomic cancer study.Identification of SNPs associated with susceptibility for development of adverse reactions to radiotherapyGenome-wide association studies in Africans and African Americans: expanding the framework of the genomics of human traits and disease.Association between Single Nucleotide Polymorphisms in XRCC3 and Radiation-Induced Adverse Effects on Normal Tissue: A Meta-Analysis.Family-based analysis of eight susceptibility loci in polycystic ovary syndrome.How Will Big Data Improve Clinical and Basic Research in Radiation Therapy?Predicting outcomes in radiation oncology--multifactorial decision support systemsSystematic Evaluation of Genetic Variants for Polycystic Ovary Syndrome in a Chinese Population.A proximity-based method to identify genomic regions correlated with a continuously varying environmental variable.A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer.A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer.Analysis of single nucleotide polymorphisms and radiation sensitivity of the lung assessed with an objective radiologic endpoinSNPs in genes implicated in radiation response are associated with radiotoxicity and evoke roles as predictive and prognostic biomarkersAfrican American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men.Genome-wide linkage and regional association study of obesity-related phenotypes: the GenSalt studyMeta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate CancerInvestigation of genetic polymorphisms related to the outcome of radiotherapy for prostate cancer patientsGermline genetic profiling in prostate cancer: latest developments and potential clinical applications.Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy.DNA methylation changes at infertility genes in newborn twins conceived by in vitro fertilisation.Neurocognitive function after radiotherapy for paediatric brain tumours.The genetic epidemiology of prostate cancer and its clinical implications.Radiogenomics: the search for genetic predictors of radiotherapy response.Radiogenomics helps to achieve personalized therapy by evaluating patient responses to radiation treatment.Validation of genetic predictors of late radiation-induced morbidity in prostate cancer patients.
P2860
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
P248
Q21183971-8E159E3B-A197-4533-BF5E-F7F875E5A187Q26744485-5ABB4460-6092-48C1-8DC8-CCDCED87EBC2Q26849735-B58E2721-D5D5-41F8-8196-4343744F3A63Q27003920-8537164D-BACE-4788-BCD6-048D10DB49F0Q27009516-276D363E-E1DD-4774-8ABB-360D633D0FA6Q28249515-C9E97580-0CD4-4FEB-B3CE-19C41F0C999DQ28943332-A8538E4B-5834-49EB-94AD-DF5C05A9CBF8Q29417092-137C9393-3FD1-46CB-BB9E-972B58436502Q30234489-8CC32E89-177D-4111-A793-B06C572F8760Q31116483-E0C9D22F-20B6-4BFB-9977-4D40BE0F8290Q33733745-4ECE5CC2-DC44-4689-85BB-972FCE0A392CQ33988391-C7DBBDBE-295E-4661-BB47-F52AD0DEBD65Q34046774-EB8EFF12-30C1-4015-9F5C-E07DDF35EE3BQ34286293-C4E8697B-C164-44E9-8486-0ED488B2C236Q34314677-B4C9750D-7F98-425E-892D-7B95FE55ACA6Q35083627-C67803FC-1734-4594-9C95-7D76229E3B7FQ35084218-E6EC6760-6133-43BE-AFF2-63370A8D1E30Q35565624-1A8DEE28-0732-42D4-8276-2DE0F0D0AFB6Q35668905-1BC1E119-D986-4DCE-8FB1-A9C3C9CB80A4Q35898322-58257905-9176-4591-91CB-70DB666340EFQ35900753-F6AA8698-035A-465C-A709-D4E0695F14F5Q36014711-3D6031C7-86D3-405E-8F9F-5F5B912F4AA7Q36170795-260F16D9-F7A1-440B-AF61-93A3E6B85B93Q36590631-BCA61211-6837-426E-B1D7-DFBEBCA212A5Q36699077-4658C91A-57D1-4DB3-8EBC-BA49D8FB42F3Q36740528-D898280E-863C-4061-94D1-C0A9BC0673E6Q36813677-E58EE0D4-3C6B-46CC-9D38-0A75D8238620Q36922197-9B168287-359A-44B8-A8F5-C91C4BCFAB53Q37167067-CE732B8C-57A1-491B-B09D-16F3981CFBB9Q37227782-681C44D4-0605-44A6-AFF1-8B6B1A36B032Q37283218-19DE1A09-5B04-4E0D-9FB4-CD95FB95B56BQ37351439-959BA1DF-0D3F-4FCD-9C99-3111959AA68FQ37474516-88442A94-7F99-42BA-8A7E-4B10FC4F9B27Q37624254-C47BB917-9E08-4101-95CE-0B39C6F08FC3Q37719658-CBFC4476-8477-47D2-AC2D-FAD7A90CB0C7Q38042263-9FE1FBF3-B8A3-46DF-B1C0-74FA4D8E8701Q38168060-FB6780C2-D752-471F-869F-AEA1A4B903FCQ38294605-F0347F9B-D6A2-4B4E-B704-96A403C2E594Q38325595-F3380601-2FB5-47C6-BE90-4FF9FF718774Q38606919-17E6092F-2AA9-426F-B09A-46415EE3D098
P2860
Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer
description
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2010
@ast
im Dezember 2010 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
wetenschappelijk artikel (gepubliceerd op 2010/12/01)
@nl
наукова стаття, опублікована в грудні 2010
@uk
مقالة علمية (نشرت في ديسمبر 2010)
@ar
name
Genome-wide association study ...... diotherapy for prostate cancer
@ast
Genome-wide association study ...... diotherapy for prostate cancer
@en
type
label
Genome-wide association study ...... diotherapy for prostate cancer
@ast
Genome-wide association study ...... diotherapy for prostate cancer
@en
prefLabel
Genome-wide association study ...... diotherapy for prostate cancer
@ast
Genome-wide association study ...... diotherapy for prostate cancer
@en
P2093
P2860
P921
P3181
P1476
Genome-wide association study ...... diotherapy for prostate cancer
@en
P2093
Barry S. Rosenstein
Christopher Campbell
Harry Ostrer
Julian Moore
Lynda Kusnetz
Nelson Stone
Richard Stock
Sarah L. Kerns
William Li
Yongzhao Shao
P2860
P304
P3181
P356
10.1016/J.IJROBP.2010.07.036
P407
P577
2010-12-01T00:00:00Z